Rulonilimab
Product Specifications
CAS Number
2417124-95-7
Target
PD-1/PD-L1
Related Pathways
Cell Cycle/Checkpoint, Apoptosis, Immunology/Inflammation
Bioactivity
Rulonilimab, a human IgG1 monoclonal antibody, targets and binds to PD-1, inhibiting its downstream signaling pathways. This action potentially enables immune checkpoint inhibition and exhibits anti-tumor activity [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2855426 100 µL
Beta-Amyloid 1-40 (CT) Rabbit pAb, BF700 conjugated
Sign In for Pricing
View Details 374603-01 20 µg
PAK7, Recombinant, Human, aa425-719, His-SUMO-Tag (Serine/threonine-protein Kinase PAK 7)
Sign In for Pricing
View Details 374603-02 100 µg
PAK7, Recombinant, Human, aa425-719, His-SUMO-Tag (Serine/threonine-protein Kinase PAK 7)
Sign In for Pricing
View Details 374603-03 1 mg
PAK7, Recombinant, Human, aa425-719, His-SUMO-Tag (Serine/threonine-protein Kinase PAK 7)
Sign In for Pricing
View Details 